Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors
- PMID: 37746355
- PMCID: PMC10516147
- DOI: 10.7759/cureus.43977
Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors
Abstract
The field of cardiovascular medicine is undergoing a transformative shift towards personalized medicinal therapy, particularly in the context of post stent implantation. This narrative review explores the significance, challenges, and future directions of individualized treatment strategies for patients with coronary stents. The review highlights the pivotal role of personalized approaches in optimizing treatment efficacy and minimizing adverse events. Real-world clinical studies and trials underscore the importance of tailoring antiplatelet therapy based on platelet function testing, genetic testing, and risk scoring. These studies reveal that personalized medicinal treatment improves clinical outcomes by balancing preventing thrombotic events and mitigating bleeding risks. Challenges, including cost, test availability, patient adherence, and ethical considerations, are discussed in depth, shedding light on the complexities of implementing personalized approaches. Technological advancements, including omics data integration, artificial intelligence, and big data analytics, shape the future of personalized medicinal therapy. These tools enable precise pharmacogenomic selection of medications and the development of integrated risk-scoring systems. Patient engagement and education are also central, with empowered patients and remote monitoring contributing to collaborative decision-making. In conclusion, the narrative review underscores that personalized medicinal therapy post stent implantation holds immense promise for revolutionizing cardiovascular care. By embracing a comprehensive approach that considers genetics, clinical factors, and patient preferences, healthcare providers can optimize treatment outcomes and improve patient quality of life. The evolving landscape of personalized medicine offers a glimpse into a future where tailored treatment strategies become the cornerstone of precision cardiovascular care.
Keywords: bare metal stents; cardiovascular medicine; coronary stent implantation; drug-eluting stents; heart; implantation; stent; tailored treatment strategies; technological advancement; therapy.
Copyright © 2023, Mohamad et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the HOST-REDUCE-POLYTECH-ACS trial. Kim HS, Kang J, Hwang D, et al. Circulation. 2021;143:1081–1091. - PubMed
-
- Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis. Andersen BK, Ding D, Mogensen LJH, Tu S, Holm NR, Westra J, Wijns W. Eur Heart J Qual Care Clin Outcomes. 2022;2:99–108. - PubMed
Publication types
LinkOut - more resources
Full Text Sources